Increased apoptosis coincides with onset of involution in infantile hemangioma

Microcirculation

Volumn 5, Issue 2-3, 1998, Pages 189-195

  Razon, Maria J ^a   Kräling, Birgit M ^a   Mulliken, John B ^a   Bischoff, Joyce ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Angiogenesis; Apoptosis; Endothelial cell growth; Infantile hemangioma

Indexed keywords

AGE; APOPTOSIS; ARTICLE; CASE CONTROL STUDY; CELL DIVISION; CYTOLOGY; GROWTH, DEVELOPMENT AND AGING; HEMANGIOMA; HUMAN; INFANT; MALE; NEOVASCULARIZATION (PATHOLOGY); NEWBORN; PATHOLOGY; PRESCHOOL CHILD; SKIN; SKIN TUMOR; TUMOR REGRESSION; VASCULAR ENDOTHELIUM;

AGE FACTORS; APOPTOSIS; CASE-CONTROL STUDIES; CELL DIVISION; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASM REGRESSION, SPONTANEOUS; NEOVASCULARIZATION, PATHOLOGIC; SKIN; SKIN NEOPLASMS;

EID: 0032247721     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mn.7300009     Document Type: Article

References (19)

1. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet, E. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med 1:1024-1028.
2. Augustin HG, Braun K, Telemenakis I, Modlich U, Kuhn W. (1995). Ovarian angiogenesis: Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am J Path 147:339-351.
3. Boon LM, Enjolras O, Mulliken JB. (1996). Congenital hemangioma: Evidence of accelerated involution. J Pediatr 128:329-335.
4. Dethlefsen SM, Mulliken JB, Glowacki J. (1986). An ultrastructural study of mast cell interactions in hemangiomas. Ultrastruct Path 10:175-183.
5. Folkman J. (1995). Clinical applications of research on angiogenesis. N Eng J Med 333:1757-1763.
6. Gavrieli Y, Shennan Y, Ben-Sasson S. A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
7. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by monoclonal antibody Ki-67. J Immunol 133:1710-1715.
8. Hanahan D, Folkman J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
9. Holmgren L, O'Reilly MS, Folkman J. (1995). Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1:149-153.
10. Iwata J, Sonobe H, Furihata M, Ido E, Ohtsuki Y. (1996). High frequency of apoptosis in infantile capillary hemangioma. J Path 179:403-408.
11. Kräling BM, Razon MJ, Boon L.M, Zurakowski D, Seachord C, Darveau R P, Mulliken JB, Corless CL, Bischoff J. (1996). E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Path 148:1181-1191.
12. Mancini AJ, Smoller BR. (1996). Proliferation and apoptosis within juvenile capillary hemangiomas. Am J Dermatopathol 18:505-514.
13. Mulliken JB., Young AE. (1988). Vascular birthmarks: Hemangiomas and malformations. WB Saunders. Philadelphia,PA.
14. Mulliken JB, Glowacki, J. (1982). Hemangiomas and vascular malformations in infants and children: Classification based on endothelial characteristics. Plast Reconstr Surg 69:412-423.
15. O'Reilly MS, Holmgren L, Chen C, Folkman J. (1996). Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med 2: 689-692.
16. Parangi S, O'Reilly M, Christofori G, Holmgren L, Grosfeld J, Folkinan J, Hanahan D. (1996). Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc Natl Acad Sci USA 93:2002-2007.
17. Takahashi K, Mulliken JB, Kozakewich HPW, Rogers RA, Folkman J, Ezekowitz RAB. (1994). Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Interest 93:2357-2364.
18. Vaux DL, Strasser A. (1996). The molecular biology of apoptosis. Proc Natl Acad Sci USA 93:2239-2244.
19. Weidner N. (1995). Intratumoral microvessel density as a prognostic factor in cancer. Am J Path 147:9-19.